Marketing
Doture moj
Mladi gospon je proizvod moje sestre i njenog poglavice i dio je tima na
čelu sa njegovim mentorom koji je ovih dana dobio patent u USA za vacinu
u slučaju uporabe biološkog naoružanja.
Nešto možete pročitati na engleskom a meni se žuri jer oma idem potražiti
našeg dotura No 1 da štogod proturim na crnjaka....
Kako šta će nama ?
Pa vacina ili vakcina ljudi moji šta vam je, napisat ćemo da je za gripu...
o blože moj koja pitanja... idem ga ili njega tražiti.
Ala me svrbe dlanovi!
Ne sluša me da ubacim video pa ću evo kopirat tekst, sory.
by Wendy Rigby / KENS 5
kens5.com
Posted on July 14, 2010 at 3:17 PM
Related:
* UTSA's South Texas Center for Emerging Infectious Diseases
Gallery
*
*
*
*
See all 4 photos »
University of Texas at San Antonio scientists have been granted a patient for developing a process to create a vaccine against a disease called tularemia. It’s an infectious agent that could be deadly in the hands of terrorists.
The microscopic threat has the potential for widespread disaster and death. You may have never heard of it, but tularemia is a feared bioweapon. It’s a bacteria that when inhaled into the lungs can wreak havoc and kill 30% of the people it infects.
“The problem is if someone intentionally tries to spread this organism around, it can cause a lot of problem in the human population,” explained Karl Klose, Ph.D., director of the UTSA South Texas Center for Emerging Infectious Diseases.
Scientists at UTASA have just been granted a U.S. patent. Working with this dangerous microbe in a biosafety level three lab (BSL-3) on the UTSA campus, microbiologists have been able to genetically tweak the highly-infectious bacterium. The idea is that instead of creating disease, this crippled version will prompt protection.
“We crippled the organism so that it can no longer cause disease,” Klose explained. “And now it functions as a vaccine. It’s not dead. The organism is not dead. It just cannot cause disease anymore because we basically changed it.”
Early tests in rats and mice have been promising.
Not all modern warfare will take place on the battlefield. That’s why scientists like these are on the front lines of discovery. Their vaccine might someday be stockpiled to protect us from a tularemia attack.
Klose and his colleagues have been working on tularemia for the last decade. They say an actual vaccine that’s safe to use in people is still years away.
Post je objavljen 24.07.2010. u 15:01 sati.